Chinese Covid vaccine wins patent approval

Tianjin-based vaccine producer, CanSino Biologics, has won patent approval for its Ad5-nCOV vaccine candidate. The Covid-19 vaccine was approved in Beijing on 11 August, Chinese state-owned media reported citing documents released by China’s Intellectual Property Administration. The Ad5-nCOV candidate was co-developed by CanSino Biologics and a team of infectious disease experts, led by Chen Wei,…

Tencent turns to AI for Covid-19 treatment

A group of Chinese scientists and Shenzhen-based tech firm, Tencent have created a model that uses artificial intelligence to quickly assess the likelihood of a patient’s Covid-19 infection turning severe or life-threatening. Research, published in the gold-standard journal Nature, showed that nearly 7% of Covid-19 cases can deteriorate rapidly, resulting in a near 50% mortality…